Work

Erenumab and Galcanezumab for Chronic Migraine Refractory to OnabotulinumtoxinA: A Real-World Comparative Study

Year: 2026

Type: article

Study design: Observational Study

Source: Annals of Pharmacotherapy

DOI: 10.1177/10600280261429460

Authors: Sara Martín-Yeves, Ana Colón-López de Dicastillo, Javier Riancho, José Ramón Sánchez-de la Torre, Yésica Jiménez-López, Sonia Setién, Mercedes Misiego-Peral, Daniel Gallo, Patricia Zunzunegui-Arroyo, Arancha Sainz-Pelayo, Manuel Delgado-Alvarado

Institutions: Hospital Sierrallana, Universidad de Cantabria, Biomedical Research Networking Center on Neurodegenerative Diseases, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Instituto de Salud Carlos III

Award: G3241799250

OpenAlex ID: W7154274668

FWCI: 4.621

Cites: 27

Cited by: 1

Related to: